Skip to main content
. 2025 Jun 18;18(6):915. doi: 10.3390/ph18060915
ADC Antibody–Drug Conjugates
ADCC Antibody–Dependent Cell-mediated Cytotoxicity
ADCP Antibody–Dependent Cellular Phagocytosis
APC Antigen-Presenting Cell
CAF Cancer-Associated Fibroblast
CDC Complement-Dependent Cytotoxicity
CAN Copy Number Alteration
CRISPR Clustered Regularly Interspaced Short Palindromic Repeats
CSC Cancer Stem Cell
CTC Circulating Tumor Cell
cfDNA Circulating cell-free DNA
ctDNA circulating tumor DNA
EMA European Medicines Agency
EMT Epithelial–Mesenchymal Transition
FDA Food and Drug Administration
HIF Hypoxia-Inducible Factor 1
HRE Hypoxia-Responsive Elements
IFN Interferon
THE Interleukin
ITH Intratumor Heterogeneity
mAb Monoclonal Antibody
MMP Matrix Metalloproteinase
MDSC Myeloid-Derived Suppressor Cell
MSC Mesenchymal Stem Cell
NGS Next Generation Sequencing
NFkB Nuclear Factor kappa B
NK Natural Killer
PDGF Platelet-Derived Growth Factor
PGF Placental Growth Factor
SDF-1 Stromal Cell-Derived Factor 1
TAM Tumor-Associated Macrophage
TGF Tumor Growth Factor
TLR Toll-Like Receptor
TME Tumor Microenvironment
TNF Tumor Necrosis Factor
Treg T regulatory cell
VCAM-1 Vascular Cellular Adhesion Molecule-1
VEGF Vascular Endothelial Growth Factor